Bluefin Capital Management’s NRX Pharmaceuticals NRXP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Hold |
0
| – | -$13K | – | 490 |
|
|
2020
Q3 | – | Sell |
-8,790
| Closed | -$40K | – | 261 |
|
|
2020
Q2 | $40K | Sell |
8,790
-1,390
| -14% | -$6.33K | ﹤0.01% | 176 |
|
|
2020
Q1 | $7K | Buy |
10,180
+20
| +0.2% | +$14 | ﹤0.01% | 191 |
|
|
2019
Q4 | $16K | Hold |
10,160
| – | – | ﹤0.01% | 338 |
|
|
2019
Q3 | $17K | Hold |
10,160
| – | – | ﹤0.01% | 238 |
|
|
2019
Q2 | $24K | Buy |
+10,160
| New | +$24K | ﹤0.01% | 196 |
|
|
2019
Q1 | – | Sell |
-10,160
| Closed | -$39K | – | 269 |
|
|
2018
Q4 | $39K | Hold |
10,160
| – | – | ﹤0.01% | 212 |
|
|
2018
Q3 | $32K | Hold |
10,160
| – | – | ﹤0.01% | 278 |
|
|
2018
Q2 | $36K | Hold |
10,160
| – | – | ﹤0.01% | 245 |
|
|
2018
Q1 | $33K | Buy |
10,160
+2,160
| +27% | +$7.02K | ﹤0.01% | 223 |
|
|
2017
Q4 | $776K | Buy |
+8,000
| New | +$776K | 0.05% | 151 |
|